Hip Scope Fascia-iliaca (FI) Block Study

Femoroacetabular Impingement Clinical Trial

Official title:

Reduction of Hip Arthroscopy Post-operative Pain Using Ultrasound-guided Fascia-iliaca Block

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02365961
• Other study ID #: Pro00038232
• Status: Completed
• Phase: Phase 4
• Start date: April 2015
• Est. completion date: June 2017

Study information

• Verified date: February 2019
• Source: The Hawkins Foundation
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 84
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Scheduled for outpatient hip arthroscopy

• American Society of Anesthesiologists (ASA) 1-3

Exclusion Criteria:

• Prior surgery on ipsilateral hip

• ASA 4-6

• Chronic narcotic usage over 6 months or more than the equivalent of 20mg of morphine per day

• Current or prior placement of a spinal cord stimulator or intrathecal pump for pain control purposes

• Allergy to amide local anesthetics

• Contraindication to regional anesthesia

• BMI > 40

• Females who are pregnant or plan to get pregnant during the course of the study

Related Conditions & MeSH terms

• Acetabular Labrum Tear
• Femoracetabular Impingement
• Femoroacetabular Impingement
• Hip Dislocation
• Hip Dislocation, Congenital
• Hip Dysplasia

Intervention

Drug:
• ropivicaine

• clonidine

• Epinephrine

• Noropin

Locations

Country	Name	City	State
United States	Steadman Hawkins Clinic of the Carolinas - Greenville Health System	Greenville	South Carolina

Sponsors (1)

Lead Sponsor	Collaborator
The Hawkins Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Time in PACU	Measured time subjects spent in the post anesthesia care unit.	Duration of PACU stay in minutes from end of surgery to discharge from PACA
Other	Total Number of Episodes of Nausea and Vomiting	Occurrences of periods of nausea and vomiting	From end of surgery to discharge from PACU
Other	Hospital Readmission	Number of participants that were readmitted to the hospital	3 months
Primary	Visual Analog Scale	Pain, as measured by Visual Analog Scale (VAS). Scores are ranged from 0-10, 0 is no pain and 10 is worst possible pain. The unit of measure is units on a scale.	3 Months
Secondary	Opioid Consumption	Opioid consumption, as measured by narcotic usage (morphine milligram equivalents)	3 Months